Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford Performance Materials commercializes 3D‑printed PEKK (OXPEKK) orthopedic and craniomaxillofacial implants under its OsteoFab platform, with multiple FDA 510(k) clearances and over 4,500 patient‑matched CMF devices delivered; products such as SpineFab vertebral body replacements and suture anchors are in routine clinical use and the company is expanding into personalized orthopedic implants for extremity, trauma, oncology, and sports medicine.[2][4][7][8]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxford Performance Materials.